A meta-analysis of topical prostaglandin analogues intra-ocular pressure lowering in glaucoma therapy.
about
Comparative study of the stability of bimatoprost 0.03% and latanoprost 0.005%: a patient-use studyTreatment persistence and cost-effectiveness of latanoprost/latanoprost-timolol, bimatoprost/bimatoprost-timolol, and travoprost/travoprost-timolol in glaucoma: an analysis based on the United Kingdom general practitioner research databaseChanges in trend of newly prescribed anti-glaucoma medications in recent nine years in a Japanese local community.Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertensionTwo-year treatment patterns and costs in glaucoma patients initiating treatment with prostaglandin analogs.What comparative effectiveness research is needed? A framework for using guidelines and systematic reviews to identify evidence gaps and research priorities.Effects of prostaglandin analogues on aqueous humor outflow pathways.A randomized, controlled comparison of macroscopic conjunctival hyperemia in patients treated with bimatoprost 0.01% or vehicle who were previously controlled on latanoprostEfficacy and tolerability of mono-compound topical treatments for reduction of intraocular pressure in patients with primary open angle glaucoma or ocular hypertension: an overview of reviews.Efficacy of bimatoprost 0.03% in reducing intraocular pressure in patients with 360° synechial angle-closure glaucoma: a preliminary studyEffects of travoprost in the treatment of open-angle glaucoma or ocular hypertension: A systematic review and meta-analysisDose-response-relationship between number of laser burns and IOP reduction in cyclophotocoagulation: an animal study.Comparative efficacy and tolerability of topical prostaglandin analogues for primary open-angle glaucoma and ocular hypertension.Multicenter, prospective, open-label, observational study of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension.Citation of previous meta-analyses on the same topic: a clue to perpetuation of incorrect methods?Efficacy and Safety of Switching Latanoprost Monotherapy to Bimatoprost Monotherapy or Combination of Brinzolamide and Latanoprost.Bimatoprost 0.03% preservative-free ophthalmic solution versus bimatoprost 0.03% ophthalmic solution (Lumigan) for glaucoma or ocular hypertension: a 12-week, randomised, double-masked trialConjunctival hyperaemia with the use of latanoprost versus other prostaglandin analogues in patients with ocular hypertension or glaucoma: a meta-analysis of randomised clinical trialsLong-term Safety and Efficacy of Latanoprostene Bunod 0.024% in Japanese Subjects with Open-Angle Glaucoma or Ocular Hypertension: The JUPITER Study.Daily costs of prostaglandin analogues as monotherapy or in fixed combinations with timolol, in Denmark, Finland, Germany and SwedenEfficacy and tolerability of bimatoprost versus travoprost in patients previously on latanoprost: a 3-month, randomised, masked-evaluator, multicentre studyLatanoprost in the treatment of glaucoma.Does the intraocular pressure-lowering effect of prostaglandin analogues continue over the long term?Efficacy and safety of prostaglandin analogues in patients with predominantly primary open-angle glaucoma or ocular hypertension: a meta-analysis.Extracellular release of ATP mediated by cyclic mechanical stress leads to mobilization of AA in trabecular meshwork cells.A novel convergent synthesis of the antiglaucoma PGF2α analogue bimatoprost.Efficacy and safety of different regimens for primary open-angle glaucoma or ocular hypertension: a systematic review and network meta-analysis.Comparison of Efficacy and Ocular Surface Disease Index Score between Bimatoprost, Latanoprost, Travoprost, and Tafluprost in Glaucoma Patients.Ocular hypotensive effects of prostaglandin analogs in Japanese patients with normal-tension glaucoma: a literature review
P2860
Q33343120-B7A873C0-BC67-4BAB-AACA-337EA7565F2BQ33863644-8F084B59-707F-4E35-9045-C9D0EBF7C563Q33886940-19DCA241-D4B0-46D1-B96E-C22F8F2AD8E6Q34043309-583C8661-A1DA-474D-B1A4-3FA4C27CD155Q34188280-2606BECA-1190-4642-8196-9F984258C3F6Q34258967-78092B78-9C78-4E6B-BEEA-834EFD9AA3B4Q34393424-E7EAAB09-91ED-4837-A33B-43467BA1AD8BQ34399842-931ADE93-DF4F-4D0C-9136-E3DF86CFD9BCQ34492862-AA96FB35-51A0-4282-9431-19C4D5FBF9CCQ34545031-EF38D711-5E48-4273-8452-79D652679472Q35135324-BE5D602A-0828-4258-B6F1-F8AA241232E4Q35211468-E001523B-467A-4D8A-98EC-8DA542BFBF55Q35237431-41AD4650-9059-44D5-9120-794F4FD59E8DQ35997507-5A6DCF1F-0280-4B0E-BA53-38029EABF669Q36513394-75791F76-32F3-4913-AD3E-3086E7C11273Q36709208-033235C7-A2C6-4619-8675-2E226DE25E07Q37030839-ED4E2E00-C4DD-4A22-B636-88DCEC0B2C9AQ37091331-2CCF4709-C4AC-4CF7-8EF6-145B85155B69Q37250462-31C9F70E-0AA9-4F24-85C5-FC88B1A21C4AQ37318853-1531F3D5-5CDF-4A9C-ABD2-F62BD8309264Q37475890-EF716825-B958-482B-AC07-7A5CD26D2E18Q38261310-A29DF261-D7F4-49DC-B827-459786701FFBQ39506959-E1B9A019-CA39-4F37-AFC7-78EF0C2A44FDQ42183554-9670DAFC-551A-4235-9280-C591A0AB12FDQ42205890-F1DB522B-1329-482A-86ED-566C4461CCABQ44637557-606B6EA9-58BA-401F-847A-7B0739B4260FQ47587175-C323E974-8C3A-4C72-8C13-E32B5C8F702EQ53827949-48D0B806-F0C9-4A94-9611-82BF00FF6A56Q57071071-E84AFA11-A1C8-4E1A-9101-9BB83EC7FA1C
P2860
A meta-analysis of topical prostaglandin analogues intra-ocular pressure lowering in glaucoma therapy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
A meta-analysis of topical pro ...... lowering in glaucoma therapy.
@ast
A meta-analysis of topical pro ...... lowering in glaucoma therapy.
@en
type
label
A meta-analysis of topical pro ...... lowering in glaucoma therapy.
@ast
A meta-analysis of topical pro ...... lowering in glaucoma therapy.
@en
prefLabel
A meta-analysis of topical pro ...... lowering in glaucoma therapy.
@ast
A meta-analysis of topical pro ...... lowering in glaucoma therapy.
@en
P2093
P356
P1476
A meta-analysis of topical pro ...... lowering in glaucoma therapy.
@en
P2093
P304
P356
10.1185/030079907X178720
P407
P577
2007-03-01T00:00:00Z